Business
Anti-inflammatory drug may shorten COVID-19 recovery time – Sydney Morning Herald
A drug company says that adding an anti-inflammatory medicine to a drug already widely used for hospitalised COVID-19 patients shortens their time to recovery by an additional day.
Lilly said it planned to discuss with regulators the possible emergency use of baricitinib for hospitalised COVID-19 patients.
It would be important to know how many study participants also received steroid drugs, which have been shown in other research to lower the risk of death for severely ill, hospitalised COVID-19 patients, said Dr Jesse Goodman, former US Food and Drug Administration chief scientist now at Georgetown University who had no role in the study.
Figuring out how to best use t…
-
General13 hours agoFarmers develop ‘autofill’ tech so agricultural robots can operate around the clock
-
Noosa News19 hours agoRevealed: 75 Qld suburbs you could afford to buy in if lending standards drop
-
General16 hours agoTrump mulling whether to fire US Fed chair Powell
-
Noosa News19 hours agoNowhere is growing like this corner of Queensland. It’s changing the political game